Catalent
CTLT
#1589
Rank
โ‚น914.91 B
Marketcap
โ‚น5,040
Share price
1.13%
Change (1 day)
51.50%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

EPS for Catalent (CTLT)

EPS in 2023 (TTM): -โ‚น105.61

According to Catalent's latest financial reports the company's current EPS (TTM) is -โ‚น108.98. In 2022 the company made an earnings per share (EPS) of โ‚น191.77 a decrease over its 2021 EPS that were of โ‚น276.25.

EPS history for Catalent from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-โ‚น105.61-155.07%
2022โ‚น191.77-30.58%
2021โ‚น276.2579.67%
2020โ‚น153.75114.12%
2019โ‚น71.81-15%
2018โ‚น84.4875.44%
2017โ‚น48.15-22.97%
2016โ‚น62.52-59.56%
2015โ‚น154.60282.05%
2014โ‚น40.46-378.2%
2013-โ‚น14.55

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
โ‚น66.74-161.24%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น63.36-41.86%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น119.12 9.30%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
โ‚น539.83-595.35%๐Ÿ‡บ๐Ÿ‡ธ USA